Zacks Investment Research on MSN
Is this the right time to retain ILMN stock in your portfolio?
Illumina Inc. ILMN is making strong progress against its long-term strategy and targets, anchored by its roadmap of growing the core sequencing business, expanding multiomics, and building services, ...
SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" ...
Good day ladies and gentlemen and welcome to the Second Quarter 2024 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, ...
San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...
Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that incorporate the tech and chemistry used by its largest, top-of-the-line machines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results